Howe & Rusling Inc Sage Therapeutics, Inc. Transaction History

Howe & Rusling Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$27.52 - $37.99 $715 - $987	-26 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $963 - $1,224	26 New	26 $1,000
Q4 2020 Feb 08, 2021	SELL	$58.41 - $89.06 $1,810 - $2,760	-31 Closed	0 $0
Q2 2020 Jul 15, 2020	BUY	$25.95 - $43.15 $804 - $1,337	31 New	31 $1,000
Q1 2019 Apr 29, 2019	SELL	$89.33 - $163.65 $6,967 - $12,764	-78 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$138.11 - $169.04 $10,772 - $13,185	78 New	78 $11,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.